08.07.2011 • NewsKrkaPharmasales and profits

Slovenia's Krka Jan-June Sales Up 6% Year-On-Year

Slovenia's top pharmaceutical company Krka said on Thursday group sales rose 6% in the first half of 2011 compared with the same period last year to reach €528.8 million ($756.4 million).

In a statement after a shareholders' meeting, it said the biggest sales rise was recorded in Eastern Europe where sales jumped 12% to €134.6 million.
Krka also said it planned to list its shares on bourses outside Slovenia but gave no details.

The company also plans to continue buying its shares to up to 10% of total equity in the next three years to use them as currency for possible takeovers. At present Krka owns 5.2% of its shares.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.